600422.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 Jun 2024 @ 01:12):

Stats
Today's Volume	6.48M
Average Volume	9.14M
Market Cap	15.69B
EPS	CNY0.223 ( 2023-10-27 )
Next earnings date	( CNY0 ) 2024-06-28
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	35.74
ATR14	CNY0.0320 (0.15%)

Volume Correlation

Long: -0.17 (neutral)

Short: 0.42 (neutral)

Signal:(59.797) Neutral

KPC Pharmaceuticals, Inc. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

KPC Pharmaceuticals, Inc. Correlation - Currency/Commodity

0.20
( neutral )

0.25
( neutral )

0.00
( neutral )

-0.02
( neutral )

-0.53
( weak negative )

KPC Pharmaceuticals, Inc. Financials

Annual	2023
Revenue:	CNY7.63B
Gross Profit:	CNY3.28B (43.04 %)
EPS:	CNY0.590

FY	2023
Revenue:	CNY7.63B
Gross Profit:	CNY3.28B (43.04 %)
EPS:	CNY0.590

FY	2022
Revenue:	CNY8.28B
Gross Profit:	CNY3.44B (41.52 %)
EPS:	CNY0.510

FY	2021
Revenue:	CNY8.25B
Gross Profit:	CNY3.41B (41.30 %)
EPS:	CNY0.669

Financial Reports:

No articles found.

KPC Pharmaceuticals, Inc. Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

KPC Pharmaceuticals, Inc.

KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria. The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.